PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, giving promising breakthroughs throughout a variety of health care and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, far more trusted alternate for therapeutic us